Ludwig Center for Metastasis Research

Sort by

Display

Collections

Format

Format

Author/ Creator

Show more

Year

Show more

Collection

Show more

Format

Author/ Creator

Show more

Year

Show more

Collection

Show more
Ludwig Center for Metastasis Research 22 records found Search took 0.13 seconds. 
1.
The activation of the stimulator of interferon genes (STING) protein by cyclic dinucleotide metabolites plays a critical role in antitumor immunity. However, synthetic ST [...]
07 October 2024 | Chemistry[...] | Article |
2.
Cholesterol is an essential membrane component, and the metabolites from cholesterol play important biological functions to intricately support cancer progression and dam [...]
15 August 2024 | Article |
3.
The efficacy of radiotherapy (RT) is limited by inefficient X-ray absorption and reactive oxygen species generation, upregulation of immunosuppressive factors, and a redu [...]
10 September 2024 | Chemistry; Radiation and Cellular Oncology | Article |
4.
The performance of photodynamic therapy (PDT) depends on the solubility, pharmacokinetic behaviors, and photophysical properties of photosensitizers (PSs). However, highl [...]
23 August 2021 | Chemistry; Radiation and Cellular Oncology | Article |
5.
Abnormal cancer metabolism causes hypoxic and immunosuppressive tumor microenvironment (TME), which limits the antitumor efficacy of photodynamic therapy (PDT). Herein, w [...]
25 June 2024 | Chemistry; Radiation and Cellular Oncology | Article |
6.
Recent studies have linked elevated tumor aneuploidy to anti-tumor immune suppression and adverse survival following immunotherapy. Herein, we provide supportive evidence [...]
21 August 2024 | Radiation and Cellular Oncology | Article |
7.
The combination of cuproptosis and immune checkpoint inhibition has shown promise in treating malignant tumors. However, it remains a challenge to deliver copper ions and [...]
16 July 2024 | Chemistry; Radiation and Cellular Oncology | Article |
8.
Cellular senescence has been increasingly recognized as a hallmark of cancer, reflecting its association with aging and inflammation, its role as a response to deregulate [...]
30 July 2024 | Molecular Genetics and Cell Biology | Article |
9.
The low success rate of cancer nanomedicines has raised debate on the role of the enhanced permeability and retention (EPR) effect on tumor deposition of nanotherapeutics [...]
17 July 2024 | Chemistry; Radiation and Cellular Oncology | Article |
10.
Chemoradiotherapy combines radiotherapy with concurrent chemotherapy to potentiate antitumor activity but exacerbates toxicities and causes debilitating side effects in c [...]
21 February 2024 | Chemistry; Radiation and Cellular Oncology | Article |
11.
Cancer vaccines have been actively pursued to bolster antitumor immunity. Here, we designed nanoscale metal-organic frameworks (nMOFs) as locally activable immunotherapeu [...]
02 October 2020 | Chemistry; Radiation and Cellular Oncology | Article |
12.

These studies define a new mechanism-based approach to radiosensitize tumor cure by single dose radiotherapy (SDRT). Published evidence indicates that SDRT induces acu [...]

02 August 2013 | Radiation and Cellular Oncology | Article |
13.

Previous reports have implicated an induction of genes in IFN/STAT1 (Interferon/STAT1) signaling in radiation resistant and prosurvival tumor phenotypes in a number of [...]

05 January 2012 | Radiation and Cellular Oncology | Article |
14.

Rationale: Strategies to stage and treat cancer rely on a presumption of either localized or widespread metastatic disease. An intermediate state of metastasis termed [...]

10 December 2012 | Medicine; Radiation and Cellular Oncology; Surgery | Article |
15.

Background: Cancer staging and treatment presumes a division into localized or metastatic disease. We proposed an intermediate state defined by ≤5 cumulative metasta [...]

13 December 2011 | Cancer Biology; Pathology; Radiation and Cellular Oncology; Surgery | Article |
16.
17.
As heavy-metal-based nanoscale metal–organic frameworks (nMOFs) are excellent radiosensitizers for radiotherapy via enhanced energy deposition and reactive oxygen speci [...]
15 August 2023 | Chemistry; Radiation and Cellular Oncology | Article |
18.
Intimal hyperplasia (IH) is the primary cause of vein bypass graft failure. The smooth muscle cell (SMC) is a key element of IH as it phenotypically switches from a contr [...]
01 July 2015 | Radiation and Cellular Oncology; Surgery | Article |
19.
Cancer cells alter mechanical tension in their cell membranes. New interventions to regulate cell membrane tension present a potential strategy for cancer therapy. Herein [...]
27 August 2023 | Chemistry; Radiation and Cellular Oncology | Article |
20.
Statins, a class of HMG-CoA reductase inhibitors best known for their cholesterol-reducing and cardiovascular protective activity, have also demonstrated promise in cance [...]
03 August 2023 | Molecular Genetics and Cell Biology | Article |
21.
Although sonodynamic therapy (SDT) has shown promise for cancer treatment, the lack of efficient sonosensitizers (SSs) has limited the clinical application of SDT. Here, [...]
25 February 2023 | Chemistry; Radiation and Cellular Oncology | Article |
22.
Long-circulating nanomedicines efficiently deliver chemotherapies to tumors to reduce general toxicity. However, extended blood circulation of nanomedicines can increase [...]
16 November 2022 | Radiation and Cellular Oncology; Radiology | Article |

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.